Additionally, FTMGL not only inhibits the pigment deposition through antioxidant activity, but also reduces MITF expression by modulating p38 and JNK in the cAMP-PI3K/Akt and MAPK signaling pathway, thereby inhibiting melanin synthesis in melanoma cells (Pudlarz et al., 2020) (Figure 2). The gene discussed is AKT1; the disease is melanoma.